Skip to main content
Figure 3 | Cardiovascular Diabetology

Figure 3

From: Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid

Figure 3

ALA treatment ameliorated diabetes-induced myocardial mitochondrial oxidative stress. Myocardial MOS were determined by measuring (A) malondialdehyde (MDA) (B) endogenous antioxidants reduced glutathione (GSH) (C) oxidized glutathione (GSSG) (D) the ratio of GSH and GSSG (E) superoxide dismutase (SOD) activity. Results are mean values ± standard deviation. *p < 0.05 vs Control group, #p < 0.05 vs. STZ group.

Back to article page